Morning Overview on MSN
Pfizer and BioNTech pause US COVID vaccine trial after slow enrollment
Pfizer and BioNTech have paused a large U.S. clinical trial designed to test their updated COVID-19 vaccine in healthy adults ...
(AP) – A real-world test of Pfizer’s COVID-19 vaccine in more than half a million people confirms that it’s very effective at preventing serious illness or death, even after one dose. Wednesday’s ...
Pfizer (PFE) is set to report its Q3 earnings on Tuesday, November 4, before the market opens. Wall Street expects earnings of $0.64 per share, down 39.6% year-over-year, on revenue of $16.52 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results